CommentaryPolicy

Breaking Down Translation Barriers: Investigator’s Perspective

Science Translational Medicine  03 Sep 2014:
Vol. 6, Issue 252, pp. 252cm7
DOI: 10.1126/scitranslmed.3008252

You are currently viewing the abstract.

View Full Text

Abstract

From our perspective as biomedical scientists, we analyze new initiatives from U.S. federal regulatory and funding agencies aimed at accelerating the process of clinical translation.

View Full Text

Related Content